Allarity Therapeutics, Inc. announced on January 27, 2024, the chairman of its board of directors (the board), received email correspondence from Mr. James G. Cullem tendering his resignation as a member of the board. The company accepted Mr. Cullem?s resignation upon receipt of the resignation email. At the time of his resignation, Mr. Cullem did not hold any position on any committee of the Board.

In the Resignation Email, Mr. Cullem stated that he was resigning from his position as its director due to acts and omissions by its chairman of the board and the other directors that he considered directly injurious to us, its stockholders, and its creditors.